ISIS-PTP1BRx: Phase I data

Top-line data from a double-blind Phase I trial in 29 obese patients showed that 400 mg

Read the full 169 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE